. 2023 Mar 22;108(10):2676–2685. doi: 10.1210/clinem/dgad166

Table 5.

PFS in months after first-line/second-line systemic therapy with PRRT or “cold” somatostatin analogs in mPPGL

	No. of patients		Median PFS in months		PFS lower limit In months		PFS upper limit in months
	All^a	SDHx	All^a	SDHx	All^a	SDHx	All^a	SDHx
First-line PRRT	21	11	18	17	5	12	126	126
Second-line PRRT	5	2	18	11	11	11	95	20
First-line SSA	5	3	Not reached	Not reached	14	23	131	37

Abbreviations: PFS, progression-free survival; PRRT, somatostatin peptide receptor-based radionuclide therapy; SDH, succinate dehydrogenase; SSA, somatostatin analogs.

All patients including those with SDHx mutations.